Funding for this research was provided by:
Hebei Medical Science Research Project (20221149)
Article History
Received: 1 July 2022
Accepted: 8 March 2023
First Online: 20 March 2023
Declarations
:
: This study (Title: intrathecal CAR-NK cells infusion for isolated CNS relapse after allogeneic stem cell transplantation) was approved by the Research Ethic Committee of the second hospital of Hebei Medical University (Approval number: 2020-R318 and 2022-P033; Date of approval: 27-MAY-2020 and 02-DEC-2022). Written informed consent to participate in the study was obtained from the patient. The study adhered to the Declaration of Helsinki.
: Written informed consent for publication of identifying images or other personal or clinical details were obtained from the patient.
: The authors declare that they have no competing interests.